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Abstract
Exhaled air contains aerosol of submicron droplets of the alveolar lining fluid
(ALF), which are generated in the small airways of a human lung. Since the
exhaled particles are micro-samples of the ALF, their trapping opens up an
opportunity to collect non-invasively a native material from respiratory tract.
Recent studies of the particle characteristics (such as size distribution, con-
centration and composition) in healthy and diseased subjects performed under
various conditions have demonstrated a high potential of the analysis of ex-
haled aerosol droplets for identifying and monitoring pathological processes in
the ALF. In this paper we present a new method for sampling of aerosol parti-
cles during the exhaled breath barbotage (EBB) through liquid. The barbotage
procedure results in accumulation of the pulmonary surfactant, being the main
component of ALF, on the liquid surface, which makes possible the study its
surface properties. We also propose a data processing algorithm to evaluate
the surface pressure (pi) – surface concentration (Γ) isotherm from the raw data
measured in a Langmuir trough. Finally, we analyze the (pi − Γ) isotherms ob-
tained for the samples collected in the groups of healthy volunteers and patients
with pulmonary tuberculosis and compare them with the isotherm measured for
the artificial pulmonary surfactant.
Keywords: Pulmonary surfactant sampling, exhaled breath barbotage,
tensiometry
1. Introduction
With every single exhalation a human lung emits an aerosol, which contains
small droplets of alveolar lining fluid (ALF) [1, 2, 3, 4, 5, 6]. Although the mech-
anisms responsible for droplet formation are still unclear, the most probable one
is associated with the processes of closure and reopening of the airways during
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normal breathing [7, 8]. At the end of exhalation the fluid layer, lining bronchi-
oles, can collapse due to the Rayleigh instability, which results in plug formation
and airway closure. During the subsequent inhalation the rupture of the fluid
film is accompanied by droplet formation. The studies of the concentration and
size distribution of aerosols [1, 2, 3, 4, 5, 6] have demonstrated that an exhaled
air of a healthy human during normal breathing contains, on average, a few
submicron particles per cubic centimeter. In spite of the high reproducibility
of measurements within subject, both characteristics show a high inter-subject
variability and a strong dependence on the type of breathing and the breathing
maneuvers before sampling [5, 6].
Over the last years, the study of the exhaled aerosols has attracted increas-
ing interest as the particles emitted represent micro-samples of the ALF. The
analysis of the droplet composition has shown the presence of all components of
ALF in undiluted concentration [9, 10, 11]. From this point of view, the trap-
ping of exhaled particles provides a new non-invasive way to obtain the native
material from the respiratory tract. Recently some studies of the ALF samples
obtained with various capturing systems or based on the analysis of separate
droplets have been published. The differences in both droplet composition and
size distribution in the groups of subjects with chronic obstructive pulmonary
disease [6], asthma [6, 12], cystic fibrosis [12] or pulmonary tuberculosis [13]
in comparison with the healthy ones were reported. These findings indicate a
high potential of the exhaled aerosol droplet analysis as a tool to identify and
monitor of pathological processes in the ALF.
In this paper, we present a new effective way to capture and to accumu-
late aerosol particles based on the exhaled breath barbotage (EBB) procedure,
which allows one to study the surface-active properties of pulmonary surfac-
tant (PS). Being the main component of the ALF, the PS is a surface-active
lipoprotein complex produced in a human lung by type II alveolar cells [14].
The most important function of PS is to reduce the alveolar surface tension
which results in increasing pulmonary compliance and allows the lung to in-
flate much more easily, reducing thereby the work of breathing. The unique
ability of the compressed PS layer to decrease surface tension to very low, near
zero, level prevents as well atelectasis (collapse of lung alveoli) at the end of
expiration. A variety of pulmonary diseases (such as asthma, pneumonia, adult
respiratory distress syndrome, tuberculosis, etc.) are able to cause surfactant
deficiency or to change its composition, which reduces of its surface activity,
provoking alveolar instability and development of inflammatory processes in the
lung [15, 16, 17, 18, 19, 20, 21, 22, 23, 24]. Measurement of the surface-active
properties of PS is an effective way to monitor the functional state of a lung
surfactant system. In our investigation we show that the accumulation of the
captured material of the aerosol particles on the saline surface in a Langmuir
through makes it possible to examine the surface-active properties of the col-
lected material immediately after the barbotage procedure. The proposed data
processing algorithm allows us to obtain the surface pressure (pi) - surface con-
centration (Γ) isotherm from the raw data obtained in the experiment. Finally
we also analyze the (pi − Γ) isotherms obtained for the samples collected in the
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Figure 1: Experimental set up for exhaled breath barbotage and examination of the dynamic
surface-active properties of samples: 1 - Teflon tube, 2 - saliva trap, 3 - Teflon trough, 4 -
saline subphase, 5 - Delrin barriers, and 6 - platinum Wilhelmy plate.
groups of healthy volunteers and patients with lung tuberculosis and compare
them with the isotherm measured for the artificial pulmonary surfactant.
2. Materials and methods
2.1. Samples collection method
Exhaled breath barbotage
We use the procedure of barbotage (or bubbling) of exhaled air through
liquid to capture ALF droplets. The complex air motion occurred in the course
of bubble formation together with a large area of the liquid-gas interface should
lead to more frequent mechanical contacts between the droplets and the bubble
surface. Collisions of the droplets with the surface of bubbles initiate their
spreading, which facilitates the adsorption of PS. The latter accumulates at the
upper liquid-air interface as the bubbles rise. The adsorbed layer can be further
investigated by tensiometric methods.
This idea lies behind the design of the collecting system shown in Fig.1.
The system consists of a Teflon tube connected to a saliva trap through which a
patient breathes out. The other end is immersed in the saline solution filling the
Langmuir trough. Since, the inner diameter of the tube is a compromise between
two requirements, it should be large enough to help the patients breathe easier
during the procedure. On the other hand, the smaller is the diameter of bubbles,
the more frequent are the contacts between the droplets and the bubble surface,
and the higher is the efficiency of surfactant collection. The inner diameter of
the tube is 3 mm.
The collected material (saline subphase with PS adsorbed on its surface) will
be henceforth called the exhaled breath barbotate (EBB) by analogy with the
exhaled breath condensate (EBC) samples.
At the beginning of the procedure, a subject took a deep breath and then
breathed completely out through the mouth into the tube. After that, the
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bubbling was stopped and one compression-expansion circle in the Langmuir
trough was realized. After the measurements were done, the subject was asked
to exhale again. This procedure was repeated several times, which allowed us
to obtain a (pi − S) isotherms after a few exhalations.
Artificial pulmonary surfactant
A series of tests was conducted with the artificial surfactant ”Surfactant-BL”
(”Biosurf”, Russia) obtained by the extraction from bovine minced lung. The
drug was dissolved in chloroform up to the concentration of 3.36 · 10−5g/ml.
A known amount of the solution was spread by a microsyringe on the saline
subphase surface in a drop-wise manner and was allowed to elapse for complete
solvent evaporation ( 10 min).
2.2. Surface activity study
The study of the surface activity of the EBB was performed with a KSVMin-
imicro system (KSV, Finland). A Teflon rectangular trough (195 × 50 mm2)
was filled with saline (Fig.1) prepared on the basis of high purity water (with
conductivity less than 0.2 µS/cm) to avoid the influence of impurities. The sur-
face of the subphase was cleaned by gently aspirating, and the cleanliness was
confirmed by a zero reading of surface pressure. Measurements were carried out
under controled temperature (37.0± 0.2) ◦C. The presence of the hollow in the
center of the trough allowed us to bubble the exhaled breath directly through the
saline subphase filling the trough. Two Delrin barriers were employed to provide
symmetric film compression. The same barrier moving speed (5 mm/min per
barrier) was used for both film compression and expansion. Expansion started
directly after the compression was finished. The surface pressure pi was contin-
uously monitored by a platinum Wilhelmy plate during barrier moving. The
(pi− S) isotherm was measured during one compression-expansion cycle. In or-
der to study the accumulation of the pulmonary surfactant on the saline surface,
we measured such an isotherm after each of several exhalations of every subject.
2.3. Groups of subjects
Two groups of subjects were involved in the study. The control group com-
prised 15 healthy nonsmoking volunteers (7 males and 8 females) aged 23 to 43
years. The second group included 20 tubercular (TB) patients (13 males and
7 females) aged 18 to 48 years. Table 1 summarizes the main characteristics of
the groups. In preliminary experiments, it was found that the results obtained
from the same patient are significantly dependent on the patient’s motion ac-
tivity before the barbotage procedure. In order to provide for the same initial
conditions of every test, all subjects were asked to make a few exercises (e.g. to
perform several squats) just before the beginning of the procedure. This allowed
us to increase essentially the intra-subject reproducibility of the results.
The Ethical Committee of the Perm State Medical University approved the
study protocol, and in all cases informed an consent was received from the
patients.
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Table 1: The main characteristics of the groups under study
Control TB group
n=15 n=20
Sex (M/F) 7/8 13/7
Age, years 28± 4 33± 9
Infiltrative pulmanory TB in disintegration phase – 13
Fibrous-cavernous pulmonary TB – 2
Disseminated pulmonary TB
in infiltration and disintegration phases – 5
2.4. Data analysis
The efficiency of the data processing algorithm is demonstrated using the
experimental data obtained for the artificial surfactant. The (pi − S) isotherms
measured for five different initial surface concentrations of the artificial surfac-
tant are presented in Fig.2a. Compression and expansion curves do not coincide
due to the hysteresis phenomenon. Further we consider only the compression
part of each circle. The maximum surface pressure pimax corresponding to the
minimal S increases with each addition of the surfactant to the saline surface.
This parameter can be used for quantification of the surfactant content on the
subphase surface. Each curve consists of two parts differing in slope, which re-
sults from the phase transition in the surface layer from gas (low slope part) to
liquid-expanded (high slope part) phase state. This phase transition takes place
at the surface concentration Γ′, the value of which is the internal property of
the surfactant. Since the curves in Fig.2a are the fragments of the same (pi−Γ)
isotherm, we can reconstruct it from the raw data by calculating the surface
concentration.
Γ = Γ0
S0
S
, (1)
where Γ0 is the known initial surface concentration which is different for each
curve. The calculated results is shown in Fig.2b. All curves coincide, forming
the (pi − Γ) isotherm, which is the main characteristic of any surfactant.
The major problem during the study of EBB samples in the Langmuir trough
is the inability to measure the initial surface concentration of the surfactant
adsorbed at the interface during breathing. This fact does not allow the re-
construction of the (pi − Γ) isotherm from the pi(S) raw data. On the other
hand, the required dependence can be found in relative units. For any surface
concentration Γ, we can write the following expression:
Γ/Γ′ = S′/S, (2)
where S and S′ are the current surface area and the surface area corresponding
to phase transition, which are directly measured in the experiment. By chang-
ing the coordinates from pi(S) to pi(S′/S), we obtain the required isotherm,
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Figure 2: Graphes illustrating different steps of the data analysis. (a) compression-expansion
isotherms obtained for the artificial surfactant of different initial surface concentration: 1 - 11
ng · cm−2, 2 - 15 ng · cm−2, 3 - 17 ng · cm−2, 4 - 20 ng · cm−2, 5 21 ng · cm−2; (b) (pi − Γ)
isotherm; (c) (pi − Γ) isotherm measured in terms of Γ′.
where the surfactant surface concentration is measured in terms of Γ′. Such a
normalized isotherm for the artificial surfactant is given in Fig.2c.
During the EBB procedure, each exhalation adds the unknown amount of
pulmonary surfactant to the saline surface. Since a certain subject emits the
same surfactant during each exhalation, we apply normalization (2) to the EBB
sample data. To determine S′, every pi(S) curve was fitted by two linear func-
tions. The abscissa of their intersection was assumed as S′. Hence, we get
the non-dimensional parameter S′/S, which describes the normalized surface
concentration of the surfactant. For statistical analysis, we took the surface
pressure pi at different S′/S and compared the results of the groups. The max-
imum surface pressure (pimax) as a function of total exhalation time t was used
as a measure of the pulmonary surfactant accumulation rate during the EBB
procedure for each subject. To this end, we interpolated the dependence pimax(t)
by a piecewise linear function to detect (pimax) at the 20th, 40th, 60th and 80th
seconds.
The results are represented as median ± standartdeviation. For unpaired
data, differences between the groups were evaluated using the Mann-Whitney
criterion (p<0.05 was assumed to be statistically significant). In the statisti-
cal analysis of the measured values, we did not assume that they had normal
distribution; that is why a nonparametric statistical test was carried out. Data
preprocessing and statistical analysis were performed using Mathematica 8.0.
3. Results
First, the intra-reproducibility of the EBB technique was estimated. For this
purpose, the EBB samples of one person (female, aged 28 years) were collected
during 5 days (1 sample a day) under similar conditions. We used the data
processing technique described above. It has been found that the variability of
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Figure 3: (pi − S) and normalized pi(S′/S) isotherms obtained after each of five exhalations
of a healthy volunteer (a and c) and a TB patient (b and d).
pimax(t) and pi(S
′/S) is low and the divergence is less than 10%, which indicates
rather good reproducibility of the EBB method.
The (pi − S) isotherms for the compression-expansion circle, measured after
each of five exhalations of a healthy volunteer, are presented in Fig.3a. In the
further analysis, we consider only the compression part of each circle. Each
subsequent curve lies above the previous one and pimax increases after each
exhalation, which indicates the accumulation of PS on the saline surface during
the EBB procedure. A comparison of the results presented in Fig.2a and Fig.3a
allows us to estimate the average amount of the PS collected by the EBB method
in healthy subjects. It makes up approximately 0.7 µg per exhalation.
The (pi − S) isotherms obtained for the EBB samples of one TB patient
are presented in Fig.3b. The curves look like those measured for the healthy
volunteer (Fig.3a). However if we take into account the shorter, on average,
exhalation time of TB patients, then we find a higher rate of PS accumulation
at the interface for this group. To summarize the results for all subjects, we
evaluated the distribution of pimax at the same moments of the total exhalation
time for control group and TB patients (Fig.4). Note that pimax grows faster
with time for the TB patients, which indicates the higher rate of emission of
aerosol particles during breathing.
The pimax(t) dependence allows us to study the variations of the aerosol
particle concentration in the exhaled air. To quantify the variations of PS
properties, one needs to compare the normalized (pi − Γ/Γ′) isotherms. The
results of applying the data processing algorithm described in Sec.2.4 to the
raw data given in (Fig.3a) and (Fig.3b) are presented in Fig.3c and Fig.3d for a
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Figure 4: Maximum surface pressure pimax obtained in the groups of healthy volunteers
(shaded boxes) and TB patients (open boxes) after a certain time. All differences are signifi-
cant (p<0.05)
healthy volunteer and a TB patient, respectively. In is seen that all curves form a
single dependence in the pi(S′/S) plane. Each subsequent curve corresponding
to the subsequent exhalation extends to higher surface concentrations in the
(pi−Γ/Γ′) isotherm, which reflects the accumulation process. It is obvious that
the first several exhalations are necessary to accumulate the surfactant sufficient
to obtain the required isotherm. Thus, there is no need to measure the pi − S
isotherm after every exhalation; it suffice to process the data obtained after the
last exhalation.
In Fig.5, we generalize all normalized isotherms for the control and TB
groups. To this end, pi(Γ/Γ′) for Γ/Γ′=0.75,1,1.25,1.5,1.75,2 were calculated for
all subjects and the results were summarized using Box-and-Whisker plots. The
difference between the healthy and TB subjects is not significant in the range of
Γ/Γ′ < 1 when the surfactant layer is in a gaseous phase state. The difference
becomes significant (p<0.05) at larger Γ/Γ′. Surface pressure pi(Γ/Γ′) values
are summarized in Table2.
For comparison we analyze the results obtained for the artificial surfactant.
The surface pressure values for healthy subjects coincide with those for the
artificial surfactant at the defined level of significance (p = 0.05). On the
contrary, the isotherms of TB subjects demonstrate significant difference from
the isotherms of both the artificial system and the control group. The surface
pressure values are smaller in TB group which says of the less surface activity
of the samples.
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Figure 5: Box-and-Whisker diagram for the surface pressure obtained from the normalized
isotherms pi(Γ/Γ′); blue rectangles correspond to controls and the gray ones to TB patients.
Stars indicate the level of significance estimated by Mann-Whitney criteria: ∗- p<0.05, ∗∗-
p<0.01.
4. Discussion
In this paper we have demonstrated the possibility of examining the sur-
face active properties of the PS obtained by the new noninvasive way, which is
based on capturing the aerosolized ALF droplets in the course of exhaled breath
barbotage. Since the surfactant is accumulated on the surface of the saline sub-
phase filling the Langmuir trough, it becomes possible to measure the surface
properties immediately after collecting, escaping the preliminary extraction or
separation procedures, as it takes place for EBC or BAL. The proposed tech-
nique is simple and inexpensive to implement and effortless to patients which
makes it preferable for kids, elder people or patients with severe diseases. The
EBB surface properties demonstrate high reproducibility in both intra-subject
and inter-subject tests. The data processing allowing one to reconstruct the
(pi − Γ) isotherm in terms of Γ′ can be useful for studies where it is impossible
to measure surfactant concentration directly.
It is interesting to discuss the sensitivity of the method to the rate of aerosol
particle emission. Recently it has been shown [5, 6] that the variation of particle
emission is low within subjects and it can be rather high between subjects. In
our study, the higher concentration of the particles in expired air would result
in the higher concentration of the pulmonary surfactant on the saline surface
at the end of one exhalation and, therefore, the larger value of pimax at the end
of surface compression. Thus, the rate of pimax growth with total exhalation
time provides the information about the emission rate. On the other hand,
the emission rate in no way can influence the pi(Γ/Γ′) isotherm. Actually the
form of this isotherm is defined by the surface activity of PS rather than by its
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Table 2: The surface pressure pi under different values of surface density Γ/Γ′ for artificial
PS and EBB samples of control and TB groups
hline Surface pressure pi, dyn/cm
Γ/Γ′ artificial CG TB
1.0 0.99 1.0± 0.5, NS 0.8± 0.5, NS
1.25 3.3 3.3± 0.9, NS 2.4± 0.9, p=0.005
1.5 6.8 6.5± 2.0, NS 4.5± 1.4, p=0.0001
1.75 10.4 10.1± 2.7, NS 7.2± 2.2, p=0.0002
2.0 14.0 13.0± 2.9, NS 10.1± 3.0, p=0.008
2.25 17.3 16.2± 3.2, NS 13.5± 3.0, p=0.009
2.5 20.5 18.6± 3.2, NS 16.7± 2.9, p=0.014
2.75 23.4 22.4± 4.1, NS 19.2± 3.1, p=0.003
amount. The low emission rate just means that a subject should make more
exhalations to reach the higher surface concentration values in the isotherm.
Thus, the pi(Γ/Γ′) isotherm is insensitive to the particle concentration in expired
air and can be used in a comparative analysis of the results obtained for different
subjects independently on the emission rate of particles.
These conclusions are confirmed by the dispersion of the data presented in
Fig.4 and Fig.5. Rather high variability of pimax (SD/M ≃ 60%) inside both
groups reflects the existing differences in the emission rate between the subjects.
At the same time, the results presented in pi(Γ/Γ′) isotherms (Fig.5) demon-
strate relatively high inter-individual repeatability in both groups (SD/M ≃
30% for control group and SD/M ≃ 40% for TB patients), which verifies the
isotherm form independence of the concentration of ALF particles in expired
air.
Another positive aspect of the proposed method consists in the fact that the
EBB technique eliminates the need for the control group of healthy subjects.
The (pi − Γ/Γ′) isotherm measured for artificial surfactant with well controlled
content can be applied as a standard for calibration purposes. Moreover, the
comparison with the pi(Γ/Γ′) isotherms measured for artificial mixtures contain-
ing not all components of the pulmonary surfactant complex can be used for
better interpretation of the abnormalities obtained in the pi(Γ/Γ′) isotherms of
subjects.
Let us now discuss the results obtained in the control and TB groups. First,
an essential difference in the growth rate of pimax during the total exhalation time
(Fig.4) should be noted. The main mechanism of ALF droplets generation is
the rupture of the plugs formed in airways due to the Rayleigh instability of the
liquid lining [7, 8]. Reopening of an airway during breathing is accompanied by
droplets formation. As was shown in [25, 26], an increase in the relation between
the liquid layer thickness and the airway diameter makes the liquid lining less
stable, which provokes more frequent formation of plugs. The inflammatory
processes taking place in the lung in a case of TB result in the narrowing of the
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diameter of distal airways. This leads to a higher level of the particle emission
rate, which results in the higher growth rate of pimax with total exhalation time
observed in the TB group. Similar increase in the particle emission rate in
the patients with pulmonary TB was earlier found in experiments, where the
exhaled particles were directly counted by optical methods [13].
Secondly, the results measured in the groups differ in the form of the (pi −
Γ/Γ′) isotherm (Fig.5). The isotherms obtained in the TB group have smaller
inclination, which indicates the lower surface activity of the EBB samples col-
lected in the TB patients. This fact is in agreement with the previous studies
[24, 22, 27], where the influence of pulmonary TB on the biophysical properties
of pulmonary surfactant was investigated. It has been found that the periph-
eral wall lipids of Mycobacterium tuberculosis reduce the surface activity of the
pulmonary surfactant complex. At the same time, it is known [25, 26] that the
lower surface activity leads to a less stable liquid lining in airways. This fact
correlates with a higher emission rate in the TB group discussed above.
Finally, we would like to discuss the possible applications of the proposed
method, EBB sampling and examination of the collected material, in medical
practice. The method is difficult to use for diagnostic purposes because different
lung diseases can result in the pulmonary surfactant abnormalities. Being a
non-invasive and simple way of assessing the lung surfactant functional state
the method can be useful both for screening testing and treatment monitoring.
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